Legal Representation
Attorney
G Patrick SAGE II
USPTO Deadlines
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 7, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Apr 7, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Sep 3, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 9, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 9, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 19, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 4, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 18, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| May 18, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 18, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 22, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 22, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 22, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 15, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 26, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 27, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Molecular antigens to induce the formation of antibodies in a cell for use in immunology research; cultures of viruses and recombinant viruses for use in the manufacture of medical or veterinary substances and compositions; chemical and biochemical substances for use in the manufacture of medical or veterinary substances and compositions; viral vectors for scientific and research use in the field of vaccines
Class 005
Pharmaceutical and veterinary preparations, namely, preparations for the treatment and prevention of infectious diseases, viral diseases, poxvirus diseases, Respiratory Syncytial Virus (RSV), smallpox; vaccines; vaccine vectors for medical purposes; vaccine adjuvants; biochemical adjuvants to increase the efficacy and activity of vaccines
Class 042
Development of vaccines and pharmaceutical and veterinary preparations
Classification
International Classes
001
005
042